TNDM · Transaction Mar 3, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · TNDM
+4.45% · +$0.7500 · Vol 2.1M
After hours · updated 16:31:46 ET
Tandem Diabetes Care Inc
Health Care
$17.62
Follow $TNDM
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $TNDM by emailVeridion Score
BETALOW CONF · 5 of 6 factors measuredMon Sep 21 · session closed · Markets closed · resumes Tue 9:30 ET · TNDM
MethodologyAnalyst data unavailable at compute time
TNDM
Tandem Diabetes Care Inc
Mon Sep 21 · session closed · Markets closed · resumes Tue 9:30 ET
Middle range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
59/ 100
Veridion Score
Middle range · LOW confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5 of 6 factors measured · Mon Sep 21 · session closed · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is TNDM moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Tandem Diabetes Care Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
2013
Employees
3K
Country
US
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$17.01
Day high
$17.83
Day low
$16.60
Previous close
$16.87
52W high
$28.26
-37.65% from high
52W low
$11.79
35% of range
Market cap
$1.2B
EPS
$-1.7000
Beta
0.81
Shares out
69.6M
Volume
2.1M
1.22× rel vol
Avg volume
1.7M
VWAP
$17.56
Price history computed in-house
1W
+4.82%
1M
-21.06%
3M
+22.28%
1Y
+40.18%
YTD
-19.84%
SMA 50 $19.58 · below
SMA 200 $19.65 · below
52W position 35%
TNDM overview
Related filings and maps
Public disclosures
Congress activity in TNDM
Official filing ↗
Tandem Diabetes Care, Inc. - Common Stock · Transaction Mar 3, 2026 · Filed Apr 7, 2026 · $1,001 to $15,000
Tandem Diabetes Care, Inc. - Common Stock · Transaction Sep 22, 2025 · Filed Oct 15, 2025 · $1,001 to $15,000
Tandem Diabetes Care, Inc. - Common Stock · Transaction Mar 19, 2025 · Filed Apr 10, 2025 · $1,001 to $15,000
TNDM · Transaction Mar 4, 2025 · Filed Apr 7, 2025 · $1,001 to $15,000
Federal contracts
TNDM contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for TNDM in this window.
Lobbying spend
TNDM lobbying filings, year to date.
Registered lobbying filings matched to Tandem Diabetes Care Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for TNDM in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for TNDM.
Options
Sovereign unlock shows live options positioning for TNDM.